Evaluation of the Good Governance for Medicines Programme (2004–2012)
Brief summary of findings
The principal purpose of the first comprehensive evaluation of the World Health Organization (WHO) Good Governance for Medicines (GGM) programme covering the period 2004–2012 was to analyse experiences and identify in-country lessons after eight years of implementation. Given the WHO commitment to the goal of universal health coverage, and the central role of good governance in its achievement, the basic objectives of the GGM programme are highly pertinent and timely.
The evaluation provides an opportunity to inform future work of countries, WHO and partners towards improving governance of the pharmaceutical sector.